Mr. Chung has 10 years of experience in the field of nanoparticle design, formulation and process development. He has helped several companies reach their seed stage and series A milestones, thereby increased their market cap by about 8 million and 40 million respectively. Mr. Chung received his MS degree in UCSD bioengineering and BS degree in National Tsinghua University biomedical engineering program in 2011.

Han has worked on many interdisciplinary projects focusing on integrating synthetic or biological materials with cells to engineer tissue from the micro- to macro-scale. He has helped his previous company raising more than $50,000 in seed funding and received the chance to take part in IndioBio’s accelerator program which included an award for $125k.